Seeing Is Believing

Currently out of the existing stock ratings of Matt Bottomley, 19 are a HOLD (46.34%), 13 are a BUY (31.71%), 9 are a SELL (21.95%).
Analyst Matt Bottomley, currently employed at CANACCORD, carries an average stock price target met ratio of 41.67% that have a potential upside of 28.32% achieved within 138 days.
Matt Bottomley’s has documented 63 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACB, Aurora Cannabis at 09-Feb-2024.
Analyst best performing recommendations are on APHA (APHRIA).
The best stock recommendation documented was for APHA (APHRIA) at 4/13/2021. The price target of $18 was fulfilled within 17 days with a profit of $3.15 (21.21%) receiving and performance score of 12.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2024
2 years 2 months 22 days ago
(08-Aug-2024)
1/2 (50%)
$-4.52 (-84.96%)
487
Hold Since 27-Jun-2024
$3
2 years 4 months 3 days ago
(27-Jun-2024)
3/6 (50%)
$-10 (-76.92%)
201
Hold Since 23-Sep-2020
$2
$-0.83 (-29.33%)
3 years 10 months 2 days ago
(28-Dec-2022)
2/3 (66.67%)
$-6.47 (-76.39%)
718
Hold Since 17-May-2022
$80
4 years 5 months 13 days ago
(17-May-2022)
1/2 (50%)
$11.4 (16.62%)
11
Hold
4 years 5 months 14 days ago
(16-May-2022)
4/7 (57.14%)
$6.37 (31.42%)
9
What Year was the first public recommendation made by Matt Bottomley?